Researcher
Steve Oh is the Director of the Stem Cell Bioprocessing group at A*STAR’s Bioprocessing Technology Institute. His research interests include: microcarrier cultures of pluripotent stem cells, bioreactor expansion of fetal MSC and hESC, engineered surfaces for hESC cultures, differentiation of hESC derived cardiomyocytes with small molecule inhibitors, and imaging and monitoring of pluripotent stem cells and cardiomyocytes.
Related Articles
Scaling up universal blood production
25 Aug 2021A scalable cell culture platform can generate universal red blood cells from stem cells, paving
Making heart tissue ‘beat’
14 Jan 2019The key to efficient production of heart muscle from pluripotent stem cells lies in optimizing